AGL
Agilon Health, Inc. NYSE Listed Apr 15, 2021$113.80
+8.72%
vs $104.67
Mkt Cap $1.9B
52w Low $7.48
96.0% of range
52w High $118.25
50d MA $64.21
200d MA $30.38
P/E (TTM)
-4.6x
EV/EBITDA
—
P/B
14.9x
Debt/Equity
0.3x
ROE
-83.1%
P/FCF
-15.8x
RSI (14)
65.20
ATR (14)
$9.73
Beta
0.33
50d MA
$64.21
200d MA
$30.38
Avg Volume
472.7K
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
6210 East US Highway 290 · Austin, TX 78723 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 1.04 | 1.80 | +73.1% | 27.85 | +56.5% | +117.8% | -10.6% | +9.9% | +16.7% | +3.6% | — |
| Feb 25, 2026 | AMC | -6.75 | -11.50 | -70.4% | 12.50 | -1.0% | +19.0% | -0.9% | +4.5% | -7.8% | +23.0% | — |
| Nov 4, 2025 | AMC | -0.18 | -0.27 | -50.0% | 18.11 | +3.0% | +4.0% | -7.5% | -4.3% | -1.1% | -6.2% | — |
| Aug 4, 2025 | AMC | -0.11 | -0.25 | -127.3% | 45.50 | -43.4% | -51.6% | +1.1% | -1.7% | -0.2% | -1.2% | — |
| May 6, 2025 | AMC | -0.01 | 0.03 | +393.0% | 111.50 | +5.6% | -24.0% | -5.0% | -10.2% | +2.8% | -9.1% | — |
| Feb 25, 2025 | AMC | -0.18 | -0.25 | -38.9% | 90.75 | -10.7% | -7.4% | -0.3% | -6.9% | -4.5% | +6.4% | — |
| Nov 7, 2024 | AMC | -0.10 | -0.29 | -190.0% | 69.75 | -33.3% | -34.1% | +17.4% | -13.4% | +0.5% | -9.0% | — |
| Aug 6, 2024 | AMC | -0.07 | -0.07 | +0.0% | 155.50 | +0.0% | -9.3% | -0.7% | -1.4% | -3.4% | +4.7% | — |
| May 7, 2024 | AMC | -0.02 | 0.01 | +150.0% | 124.50 | +6.4% | +4.2% | +1.3% | -1.3% | +0.4% | +5.6% | — |
| Feb 27, 2024 | AMC | -0.28 | -0.41 | -46.4% | 162.00 | -5.6% | -1.9% | -3.6% | -1.5% | +0.2% | -1.2% | — |
| Nov 2, 2023 | AMC | -0.05 | -0.06 | -20.0% | 422.25 | -14.4% | -13.2% | -10.6% | +4.3% | -6.9% | -8.3% | — |
| Aug 3, 2023 | AMC | -0.01 | -0.04 | -300.0% | 476.50 | +2.8% | +2.2% | +3.4% | -0.5% | -3.4% | -1.2% | — |
| May 9, 2023 | AMC | 0.03 | 0.04 | +33.3% | 650.25 | +2.8% | -3.9% | +0.7% | -4.1% | -1.4% | -3.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 | Barclays | Upgrade | Underweight → Equal Weight | $81 | $86.39 | $88.47 | +2.4% | -1.3% | +5.8% | +0.2% | +2.1% | +0.3% |
| May 7 | Jefferies | Upgrade | Hold → Buy | $48 | $27.85 | $43.59 | +56.5% | +117.8% | -10.6% | +9.9% | +16.7% | +3.6% |
| May 7 | Deutsche Bank | Upgrade | Hold → Buy | $49 | $27.85 | $43.59 | +56.5% | +117.8% | -10.6% | +9.9% | +16.7% | +3.6% |
| May 4 | JP Morgan | Downgrade | Neutral → Underweight | $21 | $29.58 | $27.58 | -6.8% | -8.9% | -0.7% | +4.2% | +117.8% | -10.6% |
| Apr 2 | Benchmark | Maintains | Buy → Buy | — | $9.75 | $9.32 | -4.4% | +10.2% | +30.0% | +18.8% | +11.3% | +7.4% |
| Mar 3 | Citigroup | Maintains | Neutral → Neutral | — | $15.39 | $15.22 | -1.1% | -7.8% | +23.0% | -4.9% | -9.9% | +0.3% |
| Feb 27 | Barclays | Maintains | Underweight → Underweight | — | $14.87 | $15.00 | +0.9% | -0.9% | +4.5% | -7.8% | +23.0% | -4.9% |
| Feb 27 | Wells Fargo | Maintains | Overweight → Overweight | — | $14.87 | $15.00 | +0.9% | -0.9% | +4.5% | -7.8% | +23.0% | -4.9% |
| Nov 6 | Barclays | Maintains | Underweight → Underweight | — | $18.84 | $18.43 | -2.2% | -7.5% | -4.3% | -1.1% | -6.2% | +1.5% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $18.11 | $18.66 | +3.0% | +4.0% | -7.5% | -4.3% | -1.1% | -6.2% |
| Oct 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.00 | $28.00 | +0.0% | -5.4% | +2.8% | -6.4% | -7.2% | -5.9% |
| Aug 20 | Bernstein | Downgrade | Outperform → Market Perform | — | $31.25 | $29.75 | -4.8% | -3.2% | +1.7% | +8.1% | +3.8% | -10.9% |
| Aug 15 | Jefferies | Maintains | Hold → Hold | — | $26.50 | $26.50 | +0.0% | +4.7% | +10.8% | +1.6% | -3.2% | +1.7% |
| Aug 14 | Baird | Maintains | Neutral → Neutral | — | $26.25 | $25.00 | -4.8% | +1.0% | +4.7% | +10.8% | +1.6% | -3.2% |
| Aug 6 | Barclays | Maintains | Underweight → Underweight | — | $22.00 | $21.45 | -2.5% | +1.1% | -1.7% | -0.2% | -1.2% | +3.3% |
| Aug 6 | Benchmark | Maintains | Buy → Buy | — | $22.00 | $21.45 | -2.5% | +1.1% | -1.7% | -0.2% | -1.2% | +3.3% |
| Aug 6 | Citigroup | Downgrade | Buy → Neutral | — | $22.00 | $21.45 | -2.5% | +1.1% | -1.7% | -0.2% | -1.2% | +3.3% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $59.75 | $61.00 | +2.1% | -4.2% | +0.9% | -3.5% | +0.9% | -2.2% |
| May 29 | Bernstein | Maintains | Outperform → Outperform | — | $58.75 | $58.75 | +0.0% | -5.1% | -0.4% | +1.4% | +0.9% | -3.5% |
| May 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $74.25 | $74.00 | -0.3% | -9.1% | -1.1% | -4.5% | -3.9% | -4.5% |
| May 8 | Barclays | Maintains | Underweight → Underweight | — | $84.75 | $84.00 | -0.9% | -5.0% | -10.2% | +2.8% | -9.1% | -1.1% |
| May 8 | Goldman Sachs | Maintains | Neutral → Neutral | — | $84.75 | $84.00 | -0.9% | -5.0% | -10.2% | +2.8% | -9.1% | -1.1% |
| Apr 28 | JMP Securities | Maintains | Market Perform → Market Perform | — | $97.50 | $97.75 | +0.3% | -1.5% | -1.0% | +12.1% | -7.7% | +5.9% |
| Apr 25 | Citigroup | Upgrade | Neutral → Buy | — | $95.50 | $99.75 | +4.5% | +2.1% | -1.5% | -1.0% | +12.1% | -7.7% |
| Apr 15 | Baird | Maintains | Neutral → Neutral | — | $140.00 | $137.50 | -1.8% | -1.2% | -1.1% | -26.9% | +3.5% | -2.4% |
| Apr 15 | TD Cowen | Maintains | Hold → Hold | — | $140.00 | $137.50 | -1.8% | -1.2% | -1.1% | -26.9% | +3.5% | -2.4% |
| Apr 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $106.25 | $135.25 | +27.3% | +26.1% | -3.4% | +6.2% | +3.3% | -1.4% |
| Apr 8 | Bernstein | Upgrade | Market Perform → Outperform | — | $106.25 | $135.25 | +27.3% | +26.1% | -3.4% | +6.2% | +3.3% | -1.4% |
| Mar 21 | Needham | Maintains | Hold → Hold | — | $102.50 | $103.00 | +0.5% | +10.5% | -1.1% | +0.0% | +0.9% | +2.0% |
| Feb 26 | Citizens Capital Markets | Maintains | Market Perform → Market Perform | — | $90.75 | $81.00 | -10.7% | -7.4% | -0.3% | -6.9% | -4.5% | +6.4% |
| Feb 26 | Needham | Maintains | Hold → Hold | — | $90.75 | $81.00 | -10.7% | -7.4% | -0.3% | -6.9% | -4.5% | +6.4% |
| Feb 26 | RBC Capital | Maintains | Outperform → Outperform | — | $90.75 | $81.00 | -10.7% | -7.4% | -0.3% | -6.9% | -4.5% | +6.4% |
| Feb 26 | Stifel | Maintains | Hold → Hold | — | $90.75 | $81.00 | -10.7% | -7.4% | -0.3% | -6.9% | -4.5% | +6.4% |
| Jan 15 | Bernstein | Maintains | Market Perform → Market Perform | — | $68.75 | $72.00 | +4.7% | +2.5% | +5.0% | +4.4% | +10.4% | +4.1% |
| Jan 10 | Citigroup | Upgrade | Sell → Neutral | — | $54.75 | $55.00 | +0.5% | +11.0% | +18.5% | -4.5% | +2.5% | +5.0% |
| Jan 10 | Needham | Maintains | Hold → Hold | — | $54.75 | $55.00 | +0.5% | +11.0% | +18.5% | -4.5% | +2.5% | +5.0% |
| Nov 19 | RBC Capital | Maintains | Outperform → Outperform | — | $39.25 | $39.00 | -0.6% | +1.3% | +5.0% | +6.6% | +6.2% | +19.6% |
| Nov 13 | Citigroup | Maintains | Sell → Sell | — | $46.75 | $46.75 | +0.0% | +0.5% | -9.0% | -7.6% | -0.6% | +1.3% |
| Nov 12 | Stifel | Maintains | Hold → Hold | — | $54.00 | $53.25 | -1.4% | -13.4% | +0.5% | -9.0% | -7.6% | -0.6% |
| Nov 11 | TD Cowen | Maintains | Hold → Hold | — | $46.00 | $46.50 | +1.1% | +17.4% | -13.4% | +0.5% | -9.0% | -7.6% |
| Nov 11 | JMP Securities | Downgrade | Market Outperform → Market Perform | — | $46.00 | $46.50 | +1.1% | +17.4% | -13.4% | +0.5% | -9.0% | -7.6% |
| Nov 11 | Barclays | Maintains | Underweight → Underweight | — | $46.00 | $46.50 | +1.1% | +17.4% | -13.4% | +0.5% | -9.0% | -7.6% |
| Nov 8 | William Blair | Downgrade | Outperform → Market Perform | — | $69.75 | $46.50 | -33.3% | -34.1% | +17.4% | -13.4% | +0.5% | -9.0% |
| Oct 29 | Citigroup | Downgrade | Neutral → Sell | — | $67.50 | $66.00 | -2.2% | -6.7% | -2.4% | +3.7% | +5.9% | -1.1% |
| Oct 8 | Evercore ISI | Maintains | In Line → In Line | — | $78.75 | $78.00 | -1.0% | +0.0% | -1.0% | +6.4% | -3.0% | +8.7% |
| Oct 2 | BofA Securities | Downgrade | Buy → Underperform | — | $91.75 | $90.50 | -1.4% | -2.5% | -11.7% | +1.6% | -1.9% | +0.0% |
| Aug 9 | Deutsche Bank | Maintains | Hold → Hold | — | $140.00 | $138.50 | -1.1% | -1.4% | -3.4% | +4.7% | -8.1% | -4.1% |
| Aug 8 | Benchmark | Maintains | Buy → Buy | — | $141.00 | $142.50 | +1.1% | -0.7% | -1.4% | -3.4% | +4.7% | -8.1% |
| Aug 7 | RBC Capital | Maintains | Outperform → Outperform | — | $155.50 | $155.50 | +0.0% | -9.3% | -0.7% | -1.4% | -3.4% | +4.7% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $151.00 | $150.00 | -0.7% | -4.8% | -1.9% | +9.0% | +2.3% | +4.0% |
No insider trades available.
8-K
Agilon Health, Inc. -- 8-K Filing
I don't have sufficient substantive information from this filing summary to provide meaningful insight for investors, as the details provided are technical metadata rather than material business developments or disclosures.
Jun 3
8-K · 5.02
!!! Very High
agilon health, inc. -- 8-K 5.02: Executive Change
Agilon Health (AGL) appointed O'Rourke as Chief Executive Officer and President effective May 7, 2026, signaling leadership transition that investors should monitor for strategic direction changes.
Apr 27
8-K · 5.03
! Medium
Unknown — 8-K 5.03: Amendment to Articles / Bylaws
AGL shareholders approved charter amendments at a special meeting, potentially altering governance structure or operational authority, which could affect future decision-making flexibility and shareholder rights.
Mar 30
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
AGL is executing a reverse stock split, which consolidates shares but doesn't increase intrinsic value—investors should watch for post-split price momentum and whether this signals financial distress or restructuring needs.
Mar 18
8-K · 7.01
! Medium
agilon health, inc. -- 8-K 7.01: Regulation FD Disclosure
Agilon Health disclosed its Q4 2025 and full-year financial results through an investor presentation, providing shareholders with updated performance metrics and operational guidance.
Feb 25
8-K · 1.01
! Medium
agilon health, inc. -- 8-K 1.01: Financing / Debt Agreement
Agilon Health amended its debt agreement on February 12, 2026, modifying existing financing terms, though specific details about the amendment's financial impact require reviewing the full agreement.
Feb 12
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Clayton, Dubilier & Rice, Llc | 4,000,000 | $32M | New | Mar 2026 |
| 2 | North Peak Capital Management, Llc | 1,545,537 | $12M | New | Mar 2026 |
| 3 | Aqr Capital Management Llc | 974,897 | $8M | New | Mar 2026 |
| 4 | D.e. Shaw & Co | 742,218 | $6M | New | Mar 2026 |
| 5 | Vanguard Capital Management Llc | 538,536 | $4M | New | Mar 2026 |
| 6 | Renaissance Technologies Llc | 149,043 | $1M | New | Mar 2026 |
| 7 | Vanguard Portfolio Management Llc | 110,835 | $877K | New | Mar 2026 |
| 8 | Two Sigma Investments, Lp | 99,352 | $786K | New | Mar 2026 |
| 9 | Northern Trust Corp | 96,100 | $760K | New | Mar 2026 |
| 10 | Ieq Capital, Llc | 68,011 | $538K | New | Mar 2026 |
| 11 | Ubs Group Ag | 58,120 | $460K | New | Mar 2026 |
| 12 | Invesco Ltd. | 40,536 | $321K | New | Mar 2026 |
| 13 | Acadian Asset Management Llc | 37,896 | $296K | New | Mar 2026 |
| 14 | Bank Of New York Mellon Corp | 32,262 | $255K | New | Mar 2026 |
| 15 | Tudor Investment Corp | 32,230 | $255K | New | Mar 2026 |
| 16 | Nuveen, Llc | 31,996 | $253K | New | Mar 2026 |
| 17 | Cwm, Llc | 31,048 | $246K | New | Mar 2026 |
| 18 | Bnp Paribas Financial Markets | 25,780 | $204K | New | Mar 2026 |
| 19 | Russell Investments Group, Ltd. | 21,209 | $168K | New | Mar 2026 |
| 20 | Susquehanna International Group, Llp | 11,570 | $92K | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.90B
Enterprise Value
$1.61B
P/E (TTM)
-4.64x
Forward P/E
—
PEG Ratio
-0.01x
P/B
14.87x
P/S
0.32x
P/FCF
-15.83x
EV/EBITDA
—
Shares Out
16.6M
Financials (TTM)
Revenue
$5.93B
Net Income
-$405.3M
EBITDA
-$368.9M
Free Cash Flow
-$119.0M
Op Cash Flow
-$105.8M
EPS Basic
$-24.50
EPS Diluted
$-24.50
EPS Forward
$-5.38
Gross Margin
-3.2%
Op Margin
-7.1%
Net Margin
-6.8%
Balance Sheet
Total Assets
$1.27B
Total Liab.
$1.14B
Total Equity
$126.7M
Cash
$285.1M
LT Debt
$15.8M
Book Value/Sh
$7.65
Debt/Equity
0.29x
Current Ratio
1.02
Quick Ratio
1.02
Returns & Growth
ROE
-83.1%
ROA
-30.8%
ROIC
-196.7%
Rev Growth YoY
-2.1%
EPS Growth YoY
-55.6%
Price Returns
2W
+17.6%
1M
+230.2%
3M
+526.5%
6M
+466.8%
12M
+66.3%
Technicals
52W High
$118.25
52W Low
$7.48
50d MA
$64.21
200d MA
$30.38
RSI (14)
65.20
ATR (14)
$9.73
Beta
0.33
Avg Volume
473K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
4
Ex-Div Date
Jun 20, 2008
Analyst Price Targets
Consensus
$24.50
High
$33.00
Low
$16.00
Median
$24.50
Data updated apr 24, 2026 4:34pm
· Source: financialmodelingprep.com